NCT03418038 2026-03-18Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic LeukemiaMayo ClinicPhase 2 Recruiting80 enrolled
NCT05498220 2025-09-02Polatuzumab Vedotin With R-GDP in Relapsed/Refractory Diffuse Large B-cell LymphomaUNC Lineberger Comprehensive Cancer CenterPhase 2 Active not recruiting5 enrolled